Systematic investigation and comparison of FDA-approved immunosuppressive drugs FK506, cyclosporine and rapamycin for neuromuscular regeneration following chronic nerve compression injury

Regenerative Medicine, Ahead of Print.

Source: Future Medicine: Regenerative Medicine - October 11, 2021 Category: Genetics & Stem Cells Authors: Lucas Degrugillier Katharina M Prautsch Dirk J Schaefer Raphael Guzman Daniel F Kalbermatten Stefan Sch ären Srinivas Madduri Source Type: research